Biocon’s subsidiary has entered into a co-development and commercialisation agreement with Mexican company Laboratorios PiSA for generic recombinant human insulin for the US market. Speaking to ...
NEW DELHI: Biotechnology major Biocon has entered into an agreement with Laboratorios PiSA for codevelopment and commercialisation of generic recombinant human insulin for the US market The Tribune, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results